Skip to main content

A Placebo-Controlled Study of the Effects of L-Tryptophan in Patients with Premenstrual Dysphoria

  • Chapter
Tryptophan, Serotonin, and Melatonin

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 467))

Abstract

In a randomized controlled clinical trial, 37 patients with premenstrual dysphoric disorder were treated with L-tryptophan 6g per day and 34 were given placebo. The treatments were given under double-blind conditions for 17 days, from the time of ovulation to the third day of menstruation, during three consecutive cycles. Visual Analog Mood Scales revealed a significant (p = 0.004) therapeutic effect of L-tryptophan relative to placebo for the cluster of mood symptoms comprising the items dysphoria, mood swings, tension and irritability. These results suggest that increasing serotonin synthesis during the late luteal phase of the menstrual cycle is therapeutic in patients with premenstrual dysphoric disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Psychiatric Association, 1987, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, American Psychiatric Association, Washington, DC.

    Google Scholar 

  • American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, 4th ed., American Psychiatric Association, Washington, DC.

    Google Scholar 

  • Beitman, B.D. and Dunner, D.L., 1982, L-Tryptophan in the maintenance treatment of bipolar II manic-depressive illness, Am J Psychiatry. 139:1498–1499.

    PubMed  CAS  Google Scholar 

  • Bond, A. and Lader, M., 1974, The use of analogue scales in rating subjective feelings, Br J Med Psychol. 47:211–218.

    Article  Google Scholar 

  • Chouinard, G., Jones, B.D., Young, S.N., and Annable, L., 1979, Potentiation of lithium by tryptophan in a patient with bipolar illness, Am J Psychiatry. 136:719–720.

    PubMed  CAS  Google Scholar 

  • Eriksson, E., Hedberg, M.A., Andersch, B., and Sundblad, C., 1995, The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome, Neuropsychopharmacology. 12:167–176.

    Article  PubMed  CAS  Google Scholar 

  • Heninger, G.R., 1995, Indoleamines: The role of serotonin in clinical disorders, in: Psychopharmacology: The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, eds., pp. 471–482, Raven Press, New York.

    Google Scholar 

  • Hertz, D. and Sulman, F.G., 1968, Preventing depression with tryptophan, Lancet. i:531–532.

    Article  Google Scholar 

  • Landry, P., Chouinard, G., and Primeau, F., 1991, Lithium-tryptophan combination in the maintenance treatment of bipolar affective illness, Lithium. 2:135–140.

    Google Scholar 

  • Morand, C., Young, S.N., and Ervin, F.R., 1983, Clinical response of aggressive schizophrenics to oral tryptophan, Biol Psychiatry. 18:575–578.

    PubMed  CAS  Google Scholar 

  • Reid, R.L., 1985, Premenstrual syndrome, Curr Probl Obstet Fertil. 8:1–57.

    Google Scholar 

  • Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, C., Reid, R., Grover, D., and Streiner, D., 1995, Fluoxetine in the treatment of premenstrual dysphoria, N Engl J Med. 332:1529–1534.

    Article  PubMed  CAS  Google Scholar 

  • Thomson, J., Rankin, H., Ashcroft, G.W., Yates, C.M., McQueen, J.K., and Cummings, S.W., 1982, The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo, Psychol Med. 12:741–751.

    Article  PubMed  CAS  Google Scholar 

  • Tollefson, G.D., 1995, Selective serotonin reuptake inhibitors, in: The American Psychiatric Press Textbook of Psychopharmacology, A.F. Schatzberg and C.B. Nemeroff, eds., pp. 161–182, American Psychiatric Press, Inc., Washington, DC.

    Google Scholar 

  • Volavka, J., Crowner, M., Brizer, D., Convit, A., van Praag, H.M., and Suckow, R.F., 1990, Tryptophan treatment of aggressive psychiatric inpatients, Biol Psychiatry. 28:728–732.

    Article  PubMed  CAS  Google Scholar 

  • Wilkins, K., 1990, Eosinophilia-myalgia syndrome, Can Med Assoc J. 142:1265–1266.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Steinberg, S., Annable, L., Young, S.N., Liyanage, N. (1999). A Placebo-Controlled Study of the Effects of L-Tryptophan in Patients with Premenstrual Dysphoria. In: Huether, G., Kochen, W., Simat, T.J., Steinhart, H. (eds) Tryptophan, Serotonin, and Melatonin. Advances in Experimental Medicine and Biology, vol 467. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4709-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4709-9_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7133-5

  • Online ISBN: 978-1-4615-4709-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics